Report
Jonathan Moreland
EUR 9.07 For Business Accounts Only

InsiderInsights Daily Ratings Report: April 17, 2023

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
Underlyings
Alta Equipment Group Inc.

APPLIED BLOCKCHAIN INC

Chembio Diagnostics Inc.

Chembio Diagnostics and its subsidiaries develop, manufacture, and commercialize point-of-care diagnostic tests that are used to detect and diagnose diseases. The company's product commercialization and product development activities are focused on infectious disease testing and technology collaborations. In infectious disease, the company is commercializing tests for human immunodeficiency virus and Syphilis, Zika virus, and developing tests for malaria, dengue virus, chikungunya virus, ebola, lassa, Marburg, leptospirosis, Rickettsia typhi, Burkholderia pseudomallei, and Orientia tsutsugamushi, individually or as part of fever panel tests.

Domo Incorporated

Domo provides a platform that digitally connects people, data and systems in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company's platform provides access to data through a set of connection options, including connectors. The company's data warehouse, Adrenaline, stores data from across the business. Fusion is the company's data transformation engine that sorts customer data. The company's Explorer analytics suite allows users to analyze, display, share and interact with data through visualizations. With the Domo Appstore, APIs and developer tool kits, the company enables an ecosystem of partners to build applications on the platform.

MERUS B V

Oncternal Therapeutics Inc

Oncternal Therapeutics is a clinical-stage biopharmaceutical company focused on the development of oncology therapies for the treatment of cancers with critical unmet medical need. The company's clinical pipeline consists of its main program, cirmtuzumab, a humanized monoclonal antibody that binds to Receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1), and TK216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. The company is also developing a chimeric antigen receptor T-cells product candidate that targets ROR1.

The Howard Hughes Corporation

Tillys

Tilly's is a retailer of casual apparel, footwear and accessories for young men, young women, boys and girls. The company's stores are located in malls, lifestyle centers, power centers, community centers, outlet centers and street-front locations. Customers may also shop online, where the company features the same assortment of product as is carried in its stores, supplemented by additional online-only styles. The company provides a mix of merchandise for young men, young women, boys and girls across the apparel, footwear and accessories categories. The company's apparel merchandise includes branded, fashion, and core styles for tops, outerwear, bottoms, and dresses.

Zoom Video Communications, Inc.

Provider
InsiderInsights.com
InsiderInsights.com

Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.

Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.

InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.

Analysts
Jonathan Moreland

Other Reports on these Companies
Other Reports from InsiderInsights.com

ResearchPool Subscriptions

Get the most out of your insights

Get in touch